Open-access Evolution of mortality attributable to passive smoking in the 27 Brazilian capitals, 2009-2021

ABSTRACT

Objective:  To estimate the mortality attributable to passive smoking in the population aged 35 years old and older, by gender, in the 27 Brazilian state capitals, from 2009 to 2021.

Methods:  A prevalence-dependent method was used, based on the calculation of population attributable fractions (PAF). Deaths from diseases causally related to passive smoking were obtained from the Mortality Information System of the Brazilian Unified Health System (SIM/SUS); prevalence data were taken on SHS exposure were obtained from Vigitel surveys (2009-2021); and relative risks were obtained from a meta-analysis. Mortality attributable to passive smoking and mortality rates were estimated by capital city, year, gender, and cause of death. Trends in crude mortality rates attributable to passive smoking were analyzed using joinpoint regression models.

Results:  Passive smoking accounted for 64,913 deaths in all Brazilian state capitals between 2009 and 2021. Cardiovascular diseases were the main cause of death in both genders. The mortality rate attributed to passive smoking decreased from 33.1/100,000 deaths in 2009 to 15.4/100,000 deaths in 2021. This reduction was observed in all 27 Brazilian state capitals, both overall and by gender.

Conclusion:  Passive smoking was responsible for 1.4% of all deaths in Brazil during the period 2009-2021 and showed a favorable trend, with rates decreasing by half during the period.

Keywords:
Tobacco use disorder; Mortality; Brazil; Cardiovascular diseases; Epidemiology

RESUMO

Objetivo:  Estimar a mortalidade atribuível ao tabagismo passivo na população de 35 anos ou mais, por sexo, nas 27 capitais brasileiras, no período de 2009 a 2021.

Métodos:  Utilizou-se um método dependente de prevalência, baseado no cálculo de Frações Atribuíveis à População (FAP). As mortes por doenças causalmente relacionadas ao tabagismo passivo foram obtidas do Sistema de Informações sobre Mortalidade do Sistema Único de Saúde (SIM/SUS); a prevalência, dos inquéritos do Sistema de Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico (Vigitel, 2009-2021); e os riscos relativos, de uma metanálise. A Mortalidade Atribuível (MA) ao tabagismo passivo e suas taxas foram estimadas por capital, ano, sexo e causas de morte. As tendências das taxas brutas de mortalidade atribuível ao tabagismo passivo foram analisadas aplicando modelos de regressão joinpoint.

Resultados:  O tabagismo passivo foi responsável por 64.913 mortes em todas as capitais brasileiras entre 2009 e 2021. As doenças cardiovasculares foram a principal causa de morte em ambos os sexos. A taxa de MA ao tabagismo passivo diminuiu de 33,1/100 mil mortes em 2009 para 15,4/100 mil mortes em 2021. Essa redução foi observada em todas as 27 capitais brasileiras, tanto de forma global quanto por sexo.

Conclusão:  O tabagismo passivo foi responsável por 1,4% de todas as mortes nas capitais brasileiras no período de 2009 a 2021 e apresentou uma tendência favorável, com as taxas diminuindo pela metade ao longo do período.

Palavras-chave:
Tabagismo; Mortalidade; Brasil; Doenças cardiovasculares; Epidemiologia

INTRODUCTION

Passive smoking constitutes a major global public health problem1, being responsible for approximately 1.3 million deaths annually worldwide2. More than 600 scientific studies have demonstrated its harmful effects3, establishing a causal association with lung cancer and ischemic heart disease in adults4. In addition, a recent meta-analysis expanded the evidence of causality to other diseases, including chronic obstructive pulmonary disease (COPD), cerebrovascular disease, type 2 diabetes mellitus, asthma, lower respiratory tract infections, and breast cancer5.

The impacts of secondhand smoke on health have driven the formulation of effective public policies and population-based strategies, consolidated in the World Health Organization Framework Convention on Tobacco Control (WHO/FCTC) and the WHO’s 2008 MPOWER package2. In Brazil, although the WHO/FCTC was ratified in 2005, measures to protect against secondhand smoke began with Law No. 9.294/19966 and its subsequent amendments in 2011 (Law No. 12.546/2011)7 and 2014 (Decree No. 8.262/2014)8. These amendments included a national ban on the advertising, promotion, and sponsorship of tobacco products; the strengthening of smoking cessation programs through the provision of treatment in primary care within the Brazilian Unified Health System (Sistema Único de Saúde - SUS); and the prohibition of tobacco consumption in collective environments, both public and private7,8. To assess the impact of these measures, it is essential to estimate the prevalence and attributable mortality (AM) of active and passive smoking, as well as to examine potential changes over time.

The first estimate of the prevalence of passive smoking in Brazil was conducted in 1989 through the National Health and Nutrition Survey, which identified a prevalence of 31.7% among adults9. In 2003, the Household Survey on Risk Behaviors and Self-Reported Morbidity of Non-Communicable Diseases and Conditions was conducted. According to data from this survey, across the 27 Brazilian capitals, the prevalence of passive smoking ranged from 13% in Campo Grande to 26% in Recife10. Since 2009, the Surveillance System for Risk and Protective Factors for Chronic Diseases by Telephone Survey (Sistema de Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico - Vigitel) has annually reported the prevalence of passive smoking in Brazilian capitals. Between 2009 and 2023, a significant reduction in prevalence was observed among adults aged 18 years old or older, decreasing from 12.7% to 6.4% at home and from 12.1% to 7% in the workplace11,12.

In Brazil, eight studies have estimated mortality attributable to passive smoking 13,14,15,16,17,18,19,20; however, none analyzed this mortality by federative unit or capital, nor did they include diseases more recently associated with this exposure5. Brazil is a country of continental dimensions and exhibits substantial demographic, socioeconomic, and epidemiological inequalities. Therefore, detailed regional estimates are essential to assess the impact of smoke-free environment policies, strengthen evidence of their effectiveness, and inform adaptations according to local needs, particularly among more vulnerable population groups.

Thus, the objective of this study was to estimate the risk attributable to passive smoking in the 27 Brazilian capitals, among the population aged 35 years old or older, by gender, from 2009 to 2021.

METHODS

Study design and context

This is a study of mortality attributable to passive smoking in the 27 Brazilian capitals from 2009-2021. Brazil is composed of five major regions: North, Northeast, Central-West, Southeast, and South. These regions are divided into 27 federative units, each with a capital. In 2024, the Brazilian population was estimated at 212,583,750, of which 23.1% (49,175,449) resided in the capitals21.

Statistical methods

To estimate AM to passive smoking, a prevalence-based method was applied, based on the calculation of Population Attributable Fractions (PAF)22. The estimates were conducted in accordance with the recommendations of the STREAMS-p guideline23.

PAF was calculated using the following formula:

P A F = q + p x R R - 1 q + p x R R

In this formula, PAF represents the population attributable fraction; p denotes the prevalence of passive smoking; q=1-p; and RR represents the risk of death among individuals exposed to passive smoking compared with those not exposed.

AM was obtained by multiplying the PAF by the Observed Mortality (OM):

A M = P A F x O M

Data sources and study population

Mortality data for the study population were obtained from the death registry database of the Mortality Information System of the Brazilian Unified Health System (Sistema de Informação de Mortalidade do Sistema Único de Saúde do Brasil - SIM/SUS). Data for each year were extracted by gender and classified, according to the 10th revision of the International Classification of Diseases (ICD-10), by capital city for the following causes: lung cancer, ischemic heart disease, cerebrovascular disease, COPD, type 2 diabetes mellitus, lower respiratory tract infections, asthma, and breast cancer5. For presentation of the results, these causes were grouped into cancer, cardiovascular diseases (CVD), and respiratory diseases.

The prevalence of passive smoking in the study population was calculated by gender and for each of the 27 Brazilian capitals, based on microdata from Vigitel collected between 2009 and 2021. Vigitel is a population-based cross-sectional survey that assesses the adult population (>18 years) residing in Brazilian capitals. The sample size for estimating the prevalence of any factor is determined assuming a 95% confidence interval and a 2% sampling error, resulting in a minimum of 2,000 interviews per capital. Sampling is conducted in two stages: random selection of households with a landline telephone and random selection of one adult resident to respond to the survey. For passive smoking, exposure is assessed using the following questions: “Does anyone living with you usually smoke inside the house?” and “Does any of your coworkers usually smoke in the same environment where you work?” Response options are “yes” or “no.” An individual was considered exposed if a “yes” response was provided to either question.

The risks of death associated with passive smoking were obtained from the study by Flor et al.5: ischemic heart disease [1.26 (1.20-1.32)], lung cancer [1.37 (1.30-1.45)], cerebrovascular disease [1.16 (1.11-1.22)], COPD [1.44 (1.21-1.71)], type 2 diabetes mellitus [1.16 (1.09-1.24)], lower respiratory tract infections [1.34 (1.23-1.45)], asthma [1.21 (1.16-1.26)], and breast cancer [1.22 (1.13-1.31)].

Statistical analysis

AM and respective crude rates of passive smoking were estimated for each Brazilian capital and for each year of the study period (2009-2021), according to gender and cause of death. Ninety-five percent confidence intervals (95%CI) were calculated for the crude rates using the following formula24:

( 100,000 / p ) ( A M ± ( 1.96 x A M )

Where p represents the denominator of the crude rate, that is, the population used for its calculation; and AM corresponds to the numerator, that is, the number of attributable deaths considered in the calculation of the crude rate.

The trend in gross AM rates was analyzed using joinpoint regression models. Initially, a maximum of three cutoff points was defined based on the Bayesian Information Criterion (BIC)25 and a significance level of 5%. The annual percentage change (APC) was calculated with 95% confidence intervals (95%CI). AM estimation was performed using Stata version 1726, and the joinpoint regression models were fitted using the Joinpoint Regression Program version 5.327.

Ethical aspects

This study used secondary data that are publicly available. Resolution No. 466/201228, which addresses research involving human beings, establishes that the use of publicly available data that do not involve the identification or possibility of identification of participants does not require approval from a Research Ethics Committee (REC).

Declaration of data availability

The database and analysis codes used in the study are available at https://svs.aids.gov.br/download/Vigitel/

RESULTS

Between 2009 and 2021, passive smoking was responsible for 64,913 deaths among individuals aged 35 years old or older in Brazilian capitals, corresponding to 4.8% of the mortality observed from the causes under study and 1.4% of the mortality from all causes during the same period. Of the total deaths attributable to passive smoking, 59.8% (38,845) occurred in men, with 56.1% (36,396) attributed to CVD. Ischemic heart disease was the leading specific cause of mortality among men (12,817 deaths; 33.6% of total attributable mortality), whereas among women, the leading cause was lower respiratory tract infections (6,628 deaths; 25.4% of total AM) (Supplementary Tables 1 and 2).

Crude AM from passive smoking decreased in all Brazilian capitals during the study period, declining from 33.1 deaths per 100,000 inhabitants in 2009 to 15.4 in 2021. This reduction was observed in both genders. Among men, rates decreased from 27.7 deaths per 100,000 inhabitants in 2009 to 12.8 in 2021, while among women, rates declined from 13.4 to 5.2 deaths per 100,000 inhabitants over the same period (Figure 1). Overall, this decrease was more pronounced between 2009 and 2016 (APC -7.8; 95%CI -10.6 to -5). In men, three periods were identified: the first showed a decreasing trend until 2016 (APC -8; 95%CI -11 to -4.2); the second showed a stable trend until 2019 (APC 0.5; 95%CI -9.6 to 3.3); and the third showed a decreasing trend between 2019 and 2021 (APC -9.2; 95%CI -14.2 to -2.4). In women, since 2009, the trend in AM rates consistently decreased (APC -6.6; 95%CI -7.5 to -5.7). The APC values and 95%CIs are presented in Table 1.

Figure 1.
Crude attributable mortality to passive smoking and their trend, for all causes, overall and by gender, in the 27 Brazilian capitals, 2009-2021.

Table 1.
Annual Percentage Change and 95% confidence interval by gender in the 27 Brazilian capitals, 2009-2021.

Table 2 presents the crude AM of secondhand smoke exposure (per 100,000 inhabitants) in Brazilian capitals in 2009 and 2021. Recife, Pernambuco (PE), registered the largest decrease, declining from 48.4 in 2009 to 17.7 in 2021. The smallest decrease was observed in Palmas, Tocantins (TO), where rates decreased from 26.8 to 22.6 over the same period. Among men, the AM of secondhand smoke exposure decreased in 26 capitals, with the exception of Palmas, where it increased from 34.2 in 2009 to 39.9 in 2021. Among women, a decrease in rates was observed in all capitals.

Table 2.
Crude attributable mortality to passive smoking (per 100,000 inhabitants) and 95% confidence intervals, by gender, in the 27 Brazilian capitals, 2009-2021.

Analysis by major groups of causes of death showed that CVD presented the highest rates throughout the study period in all Brazilian capitals (Figure 2). Recife/PE was the capital with the highest AM from passive smoking due to CVD over the entire period (Figure 3). It is noteworthy that in Belém, Pará (PA), CVD were the leading cause of death until 2020; and in Rio Branco, Acre (AC), until 2021, when they were surpassed by respiratory diseases (Supplementary Figures S1 and S2).

Figure 2.
Crude attributable mortality to passive smoking, by cause and by gender, in the 27 Brazilian capitals, 2009-2021.

Figure 3.
Crude attributable mortality to passive smoking, by cause, overall and by gender, in Recife (PE), 2009-2021.

DISCUSSION

Between 2009 and 2021, passive smoking was responsible for 64,913 deaths in the 27 Brazilian state capitals; 6 out of 10 occurred in men, mainly attributed to CVD. The leading specific cause of death related to passive smoking was ischemic heart disease among men and lower respiratory tract infections among women. Over the study period, AM from passive smoking decreased substantially, from 6,290 deaths in 2009 to 3,931 deaths in 2021.

The decrease in exposure to secondhand smoke occurred in all capitals, although with varying magnitudes, possibly related to socioeconomic factors. Recife (PE) showed the greatest reduction in both genders. A previous study conducted in Brazil also identified Pernambuco as the federative unit with the greatest decrease in tobacco exposure rates between 1990 and 201729. Palmas (TO), Macapá (Amapá - AP), Rio Branco (AC), and Boa Vista (Roraima - RR), showed the smallest reductions in AM. These capitals have a Human Development Index (HDI) below the national average30. HDI is an indicator that assesses the level of development of a population based on three fundamental dimensions: education, income, and longevity31. A study conducted in Brazil in 2011 reported a higher prevalence of secondhand smoke exposure at home and at work among individuals with lower income and lower levels of education32, highlighting the importance of addressing inequalities in the fight against tobacco consumption and strengthening existing policies and programs33.

In 2021, Campo Grande, Mato Grosso do Sul (MS), and Natal, Rio Grande do Norte (RN), presented the highest mortality rates from passive smoking. Campo Grande stands out for having the highest prevalence of tobacco use and for being among the ten capitals with the highest prevalence of passive smoking at home11. Natal, located in a federative unit with an HDI below the national average, faces limitations in access to health services, which may compromise the effectiveness of tobacco control policies and contribute to higher mortality rates30. In contrast, Cuiabá, Mato Grosso (MT), and Brasília, Federal District (DF), presented the lowest AM. Both capitals have a high HDI, a condition associated with better implementation of tobacco control policies and lower prevalence of tobacco consumption and passive smoking30. In Cuiabá (MS), the prevalence of passive smoking at home is among the lowest in the country11.

Three previous studies that estimated AM of passive smoking in Brazil using the Global Burden of Disease (GBD) methodology18,19,20 reported AM rates higher than those observed in the present study: 44.5/100,000 inhabitants18 and 32.8/100,000 inhabitants19, compared with 19.2/100,000 inhabitants in this study. Another recent study20 presented results stratified by gender: 14.2/100,000 inhabitants among men and 6/100,000 inhabitants among women, compared with 3.7/100,000 inhabitants among men and 1.5/100,000 inhabitants among women in the present study. Although the methodology used here is similar to that applied in the GBD studies, there are differences in the calculation procedures, included causes, age groups, and geographic scope. The GBD methodology adjusts for uncoded deaths and redistributes the so-called garbage codes (GC), which was not performed in the present study due to the low proportion of these codes in Brazil (<5%).

Malta et al. analyzed the effect of GC redistribution on trends in mortality from chronic diseases in Brazil (2010-2019), comparing raw data from SIM, data corrected for GC and underreporting, and data from the GBD. Despite little change in temporal trends, the corrected rates were significantly higher, with heterogeneous variation among the federative units34. Regarding causes of death, 8 were included in the present study: ischemic heart disease, CVD, lung cancer, breast cancer, lower respiratory tract infections, type 2 diabetes mellitus, COPD, and asthma. Reitsma et al.19 excluded asthma; São José et al.18 analyzed only cancer; and Salerno et al.20 included only lung cancer. The age range of the population also differed: 35 years old or older in the present study; 40 years old or older in the study by São José et al.18; 25 years old or older in the study by Reitsma et al.19; and 20 years old or older in the study by Salerno et al.20. The present study also differs from that of São José et al.18, which considered the combined burden of active and passive smoking. Furthermore, it is important to note that the present study is limited to the population of Brazilian state capitals, representing approximately 23% of the total population of the country, whereas the other studies covered the national population.

According to previous studies conducted in Brazil15,16, the AM associated with passive smoking is higher among men. This difference may be explained by the higher prevalence of exposure to secondhand smoke in the workplace among men (10.2%), which is more than double that observed among women (4.3%)11. It is important to highlight that differences in the AM of passive smoking - both overall and by specific cause and gender (ischemic heart disease among men and respiratory diseases among women) - were also reported in another study conducted by the same research group on the risk of tobacco use in Brazil35.

AM from secondhand smoke in South America are scarce36. A study conducted in Chile estimated 70 lung cancer deaths attributable to secondhand smoke37. Using the same methodology, the author estimated 387 deaths in Brazil15. A recent study reported disparities in AM for tracheal, bronchial, and lung cancer: Uruguay had the highest rates among men (42.6/100,000 inhabitants), and Argentina among women (8.8/100,000 inhabitants). Peru presented the lowest rates in both genders (3.6 and 0.7/100,000 inhabitants). Brazil occupied an intermediate position, ranking sixth lowest among men (14.2/100,000 inhabitants) and third lowest among women (6/100,000 inhabitants)20.

This study has limitations related to the estimation methods and data sources used. In estimating AM, the latency period between exposure to passive smoking and death was not considered, as both indicators were analyzed concurrently in time. This is due to the lack of specific information on latency periods, which likely vary according to the cause and level of exposure. Regarding prevalence, Vigitel is based on self-reported information, which may lead to underestimation of the prevalence of passive smoking due to recall bias. There is also the possibility of selection bias, since the sample is drawn from a telephone directory, excluding individuals without access to this service, although post-stratification weights are applied to minimize this effect. With respect to observed mortality, GC (approximately 5% of deaths) were not redistributed, as this procedure would introduce additional uncertainty into the AM estimates. As a result, mortality may be underestimated, although it is assumed that this underestimation is of small magnitude.

It is important to consider that the COVID-19 pandemic may have influenced both the quality of mortality records and the coding of causes of death in 2020 and 2021. Excess mortality and the initial absence of a specific code for COVID-19 may have led to misclassification of causes of death. Due to the lack of national studies estimating specific relative risks (RR) for the association between passive smoking and mortality in Brazil, RR estimates from a recent meta-analysis were used5. In addition, although potential variations in the age distribution of populations residing in Brazilian capitals over the 13-year period are acknowledged, mortality rates were not age-adjusted, as the objective of this study was to assess the overall burden of passive smoking, without accounting for changes in population age structure.

This study also presents important strengths. For the first time, AM from passive smoking was estimated using more recent causes of death with gender-specific prevalence data, in addition to applying the same calculation procedures and data sources across all Brazilian capitals, allowing direct comparability of results. Moreover, the temporal evolution of mortality AM from passive smoking in Brazilian capitals was analyzed for the first time. These data represent an important source of information for public policy makers. The registry from which mortality data were obtained is of high quality, with an average proportion of 3% of deaths among individuals aged 35 years old or older coded as R99 of the ICD-10 (“Ill-defined and unspecified causes of mortality”). This proportion decreased from 4.1% in 2009 to 3.4% in 2018, followed by a slight increase to approximately 4% from 2019 onward38. In all years, this proportion remained below the 10% threshold commonly used as a reference for high-quality mortality records. Another strength of this study is the adherence to recommendations aimed at improving the quality of estimates when attributing mortality to a risk factor23.

Between 2009 and 2021, 4.8% of deaths from lung cancer, ischemic heart disease, CVD, COPD, type 2 diabetes mellitus, lower respiratory tract infections, asthma, and breast cancer among individuals aged 35 years old or older in Brazilian capitals were attributable to secondhand smoke, corresponding to approximately 5,000 deaths per year. Of these attributable deaths, 6 out of 10 were due to CVD. AM to secondhand smoke was higher among men (six out of ten attributable deaths) and varied across Brazilian capitals. Overall, AM to secondhand smoke in Brazil showed a favorable trend, with rates decreasing by approximately half over the study period.

Although Brazil is a global leader in tobacco control2, additional measures are still required to further reduce tobacco consumption and passive smoking. Key strategies include sustained increases in taxation, restrictions on points of sale, strengthened enforcement against smuggling and illicit tobacco trade, incentives for alternatives to tobacco cultivation, and the implementation of plain tobacco packaging39. Tobacco control policies in Brazil should be continuously monitored, expanded, and coordinated with intersectoral actions focused on equity and social justice, in alignment with the Sustainable Development Goals (SDGs), to reduce inequalities and enhance health gains. The continued mobilization of Brazilian civil society is essential for the protection and advancement of public policies, as advocated by WHO/FCTC.

Supplementary material

Supplementary material

REFERENCES

  • 1. Dai X, Gakidou E, Lopez AD. Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. Tob Control 2022; 31: 129-37. https://doi.org/10.1136/tobaccocontrol-2021-056535
    » https://doi.org/https://doi.org/10.1136/tobaccocontrol-2021-056535
  • 2. World Health Organization. Report on the global tobacco epidemic, 2023: protect people from tobacco smoke. The MPOWER package. Genebra: World Health Organization; 2023.
  • 3. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention; 2006.
  • 4. The health consequences of involuntary smoking. a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention; 1986.
  • 5. Flor LS, Anderson JA, Ahmad N, Aravkin A, Carr S, Dai X, et al. Health effects associated with exposure to secondhand smoke: a Burden of Proof study. Nat Med 2024; 30: 1213. https://doi.org/10.1038/s41591-024-02832-y
    » https://doi.org/https://doi.org/10.1038/s41591-024-02832-y
  • 6. Brasil. Presidência da República. Casa Civil. Subchefia para Assuntos Jurídicos. Lei no 9.294/1996, de 15 de julho de 1996. Dispõe sobre as restrições ao uso e à propaganda de produtos fumígeros, bebidas alcoólicas, medicamentos, terapias e defensivos agrícolas, nos termos do § 4° do art. 220 da Constituição Federal [Internet]. Diário Oficial da União de 16 de julho de 1996 [cited on Jan 16, 2025]. Available at: https://www.planalto.gov.br/ccivil_03/leis/l9294.htm
    » https://www.planalto.gov.br/ccivil_03/leis/l9294.htm
  • 7. Brasil. Presidência da República. Casa Civil. Subchefia para Assuntos Jurídicos. Lei no 12.546/2011 de 14 de dezembro. Institui o Regime Especial de Reintegração de Valores Tributários para as Empresas Exportadoras (Reintegra); dispõe sobre a redução do Imposto sobre Produtos Industrializados (IPI) à indústria automotiva; altera a incidência das contribuições previdenciárias devidas pelas empresas que menciona; altera as Leis no 11.774, de 17 de setembro de 2008, no 11.033, de 21 de dezembro de 2004, no 11.196, de 21 de novembro de 2005, no 10.865, de 30 de abril de 2004, no 11.508, de 20 de julho de 2007, no 7.291, de 19 de dezembro de 1984, no 11.491, de 20 de junho de 2007, no 9.782, de 26 de janeiro de 1999, e no 9.294, de 15 de julho de 1996, e a Medida Provisória no 2.199-14, de 24 de agosto de 2001; revoga o art. 1º da Lei no 11.529, de 22 de outubro de 2007, e o art. 6º do Decreto-Lei no 1.593, de 21 de dezembro de 1977, nos termos que especifica; e dá outras providências [Internet]. Diário Oficial da União de 15 de dezembro de 2011 [cited on Jan 16, 2025]. Available at: https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2011/lei/l12546.htm
    » https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2011/lei/l12546.htm
  • 8. Brasil. Presidência da República. Casa Civil. Subchefia para Assuntos Jurídicos. Decreto no 8.262/2014 de 31 de maio. Altera o Decreto no 2.018, de 1º de outubro de 1996, que regulamenta a Lei nº 9.294, de 15 de julho de 1996 [Internet]. Diário Oficial da União de 2 de junho de 2014 [cited on Jan 16, 2025]. Available at: https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2014/decreto/d8262.htm
    » https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2014/decreto/d8262.htm
  • 9. Instituto Nacional de Alimentação e Nutrição. Pesquisa Nacional sobre Saúde e Nutrição - PNSN (1989). Brasília: Ministério da Saúde; 1990.
  • 10. Instituto Nacional de Câncer. Inquérito domiciliar sobre comportamentos de risco e morbidade referida de doenças e agravos não transmissíveis. Brasília: Ministério da Saúde; 2003.
  • 11. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento de Análise Epidemiológica e Vigilância de Doenças Não Transmissíveis. Vigitel Brasil 2023: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2023. Brasília: Ministério da Saúde; 2023.
  • 12. Malta DC, Stopa SR, Santos MAS, Andrade SSCA, Oliveira TP, Cristo EB, et al. Evolução de indicadores do tabagismo segundo inquéritos de telefone, 2006-2014. Cad Saúde Pública 2017; 33: (Suppl 3): e00134915. https://doi.org/10.1590/0102-311X00134915
    » https://doi.org/https://doi.org/10.1590/0102-311X00134915
  • 13. Figueiredo VC, Costa AJL. Qual é o impacto do tabagismo passivo na mortalidade por câncer de pulmão e doenças cardio-circulatórias em adultos de áreas urbanas do Brasil? In: Araújo AJ, org. Manual de condutas e práticas em tabagismo. São Paulo; Rio de Janeiro: AC Farmacêutica; Editora Guanabara Koogan; 2012. p. 92-4.
  • 14. Pinto MT, Pichon-Riviere A, Bardach A. Estimativa da carga do tabagismo no Brasil: mortalidade, morbidade e custos. Cad Saúde Pública 2015; 31: 83-97. https://doi.org/10.1590/0102-311X00192013
    » https://doi.org/https://doi.org/10.1590/0102-311X00192013
  • 15. Rezende LFM, Lee DH, Louzada MLC, Song M, Giovannucci E, Eluf-Neto J. Proportion of cancer cases and deaths attributable to lifestyle risk factors in Brazil. Cancer Epidemiol. 2019; 59: 148-57. https://doi.org/10.1016/j.canep.2019.01.021
    » https://doi.org/https://doi.org/10.1016/j.canep.2019.01.021
  • 16. Pinto M, Bardach A, Palacios A, Biz A, Alcaraz A, Rodriguez B, et al. Carga do tabagismo no Brasil e benefício potencial do aumento de impostos sobre os cigarros para a economia e redução de mortes e adoecimento. Cad Saúde Pública 2019; 35: e00129118. https://doi.org/10.1590/0102-311X00129118
    » https://doi.org/https://doi.org/10.1590/0102-311X00129118
  • 17. Pinto M, Bardach A, Palacios A, Biz A, Alcaraz A, Rodrígues B, et al. Carga de doença atribuível ao uso do tabaco no Brasil e potencial impacto do aumento por meio de impostos [Internet]. Buenos Aires: Instituto de Efectividad Clínica y Sanitaria; 2017 [cited on Jan 24, 2025]. Available at: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//carga-doenca-atribuivel-uso-tabaco-brasil.pdf
    » https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//carga-doenca-atribuivel-uso-tabaco-brasil.pdf
  • 18. São José BP, Corrêa RA, Malta DC, Passos VMA, França EB, Teixeira RA, et al. Mortalidade e incapacidade por doenças relacionadas ao tabaco no Brasil, 1990 a 2015. Rev Bras Epidemiol 2017; 20(Suppl 1): 75-89. https://doi.org/10.1590/1980-5497201700050007
    » https://doi.org/https://doi.org/10.1590/1980-5497201700050007
  • 19. GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet 2021; 397(10292): 2337-60. https://doi.org/10.1016/S0140-6736(21)01169-7
    » https://doi.org/https://doi.org/10.1016/S0140-6736(21)01169-7
  • 20. Salerno PRVO, Dallan LAP, Pereira GTR, Fernandes PMP, Terra RM, Rajagopalan S, et al. Trends in tracheal, bronchial and lung cancer attributed to smoking in South America: global burden of disease analysis 1990-2019. Rev Panam Salud Publica 2024; 48: 30. https://doi:10.26633/RPSP.2024.30
    » https://doi.org/https://doi:10.26633/RPSP.2024.30
  • 21. DATASUS. População residente [Internet]. [cited on Jan 24, 2025]. Available at: https://datasus.saude.gov.br/populacao-residente/
    » https://datasus.saude.gov.br/populacao-residente/
  • 22. Pérez-Ríos M, Montes A. Methodologies used to estimate tobacco-attributable mortality: a review. BMC Public Health. 2008; 8: 22. https://doi.org/10.1186/1471-2458-8-22
    » https://doi.org/https://doi.org/10.1186/1471-2458-8-22
  • 23. Pérez-Ríos M, Rey-Brandariz J, Galán I, Fernández E, Montes A, Santiago-Pérez MI, et al. Methodological guidelines for the estimation of attributable mortality using a prevalence-based method: the STREAMS-P tool. J Clin Epidemiol 2022; 147: 101-10. https://doi.org/10.1016/j.jclinepi.2022.03.016
    » https://doi.org/https://doi.org/10.1016/j.jclinepi.2022.03.016
  • 24. Commonwealth of Pennsylvania. Tools of the trade [Internet]. Pennsylvania: Commonwealth of Pennsylvania [cited on Oct 09, 2025]. Available at: https://www.pa.gov/agencies/health/health-statistics/statistical-resources/understanding-health-statistics/tools-of-the-trade
    » https://www.pa.gov/agencies/health/health-statistics/statistical-resources/understanding-health-statistics/tools-of-the-trade
  • 25. Martinez-Beneito MA, García-Donato G, Salmerón D. A Bayesian Joinpoint regression model with an unknown number of break-points. Ann Appl Stat 2011; 5(3): 2150-68. https://doi.org/10.1214/11-AOAS471
    » https://doi.org/https://doi.org/10.1214/11-AOAS471
  • 26. StataCorp. Stata Statistical Software: Release 17. Texas: College Station, StataCorp LLC; 2021.
  • 27. National Cancer Institute. Joinpoint Trend Analysis Software [Internet]. [cited on Jan 24, 2025]. Available at: https://surveillance.cancer.gov/joinpoint/
    » https://surveillance.cancer.gov/joinpoint/
  • 28. Brasil. Ministério da Saúde. Conselho Nacional de Saúde. Resolução no 466, de 12 de dezembro de 2012. Dispõe sobre as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Brasília: Diário Oficial da União; 2013. [ited on Jan 14, 2025]. Available at: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html
    » https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html
  • 29. Malta DC, Flor LS, Machado IE, Felisbino-Mendes MS, Brant LCC, Ribeiro ALP, et al. Trends in smoking prevalence and mortality in Brazil and federated units, 1990 and 2017. Populat Health Metr 2020; 18(Suppl 1):24. https://doi.org/10.1186/s12963-020-00215-2
    » https://doi.org/https://doi.org/10.1186/s12963-020-00215-2
  • 30. Atlas Brasil. Ranking [Internet]. [cited no Jan 14, 2025]. Available at: http://www.atlasbrasil.org.br/ranking
    » http://www.atlasbrasil.org.br/ranking
  • 31. Romão MC. Uma proposta de extensão do “Índice de Desenvolvimento Humano” das Nações Unidas. Brazil J Polit Econ. 2023; 13(4): 597-612. https://doi.org/10.1590/0101-31571993-0668
    » https://doi.org/https://doi.org/10.1590/0101-31571993-0668
  • 32. Passos VMA, Giatti L, Barreto SM. Tabagismo passivo no Brasil: resultados da Pesquisa Especial do Tabagismo, 2008. Ciênc Saúde Coletiva. 2011; 16(9): 3671-8. https://doi.org/10.1590/S1413-81232011001000004
    » https://doi.org/https://doi.org/10.1590/S1413-81232011001000004
  • 33. Alcaraz A, Pichon-Riviere A. Tobacco control in Latin America: achievements, gaps and challenges. Rev Peru Med Exp Salud Publica 2023; 40(3): 264-6. https://doi.org/10.17843/rpmesp.2023.403.13284
    » https://doi.org/https://doi.org/10.17843/rpmesp.2023.403.13284
  • 34. Malta DC, Teixeira RA, Souza JB, Aquino EC, Dantas Júnior AB, Soares Filho AM, et al. O efeito das redistribuições dos códigos garbage na evolução da mortalidade por Doenças Crônicas no Brasil, 2010 a 2019. Ciênc Saúde Coletiva 2025; 30(3): e00492024. https://doi.org/10.1590/1413-81232025303.00492024
    » https://doi.org/https://doi.org/10.1590/1413-81232025303.00492024
  • 35. Wanderlei-Flores B, Rey-Brandariz J, Corrêa PCRP, Ruano-Ravina A, Guerra-Tort C, Candal-Pedreira C, et al. Smoking-attributable mortality by sex in the 27 Brazilian federal units: 2019. Public Health 2024; 229: 24-32. https://doi.org/10.1016/j.puhe.2024.01.016
    » https://doi.org/https://doi.org/10.1016/j.puhe.2024.01.016
  • 36. López-Medina DC, Candal-Pedreira C, Rey-Brandariz J, Guerra-Tort C, García G, Martín-Gisbert L, et al. Studies estimating second-hand smoke-attributable mortality: a systematic review. Eur J Public Health 2024; 34(3): 557-65. https://doi.org/10.1093/eurpub/ckae049
    » https://doi.org/https://doi.org/10.1093/eurpub/ckae049
  • 37. Rezende LFM, Murata E, Giannichi B, Tomita LY, Wagner GA, Sanchez ZM, et al. Cancer cases and deaths attributable to lifestyle risk factors in Chile. BMC Cancer 2020; 20(1): 693. https://doi.org/10.1186/s12885-020-07187-4
    » https://doi.org/https://doi.org/10.1186/s12885-020-07187-4
  • 38. DATASUS. Mortalidade - desde 1996 pela CID-10 - DATASUS [Internet]. [cited on Jan 14, 2025]. Available at: https://datasus.saude.gov.br/mortalidade-desde-1996-pela-cid-10/
    » https://datasus.saude.gov.br/mortalidade-desde-1996-pela-cid-10/
  • 39. Pérez-Ríos M, Ahluwalia J, Guerra-Tort C, García G, Rey-Brandariz J, Mourino-Castro N, et al. Towards stronger tobacco control policies to curb the smoking epidemic in Spain. Clin Transl Oncol 2024; 26(7): 1561-9. https://doi.org/10.1007/s12094-024-03385-9
    » https://doi.org/https://doi.org/10.1007/s12094-024-03385-9
  • HOW TO CITE THIS ARTICLE:
    Flores BW, Rey-Brandariz J, Corrêa PCRP, Ravara S, Montes A, Pérez-Ríos M. Evolution of mortality attributable to passive smoking in the 27 Brazilian capitals, 2009-2021. Rev Bras Epidemiol. 2026; 29: e260017. https://doi.org/10.1590/1980-549720260017
  • FUNDING:
    none.

Edited by

Publication Dates

  • Publication in this collection
    03 Apr 2026
  • Date of issue
    2026

History

  • Received
    12 Apr 2025
  • Reviewed
    13 Oct 2025
  • Accepted
    16 Dec 2025
location_on
Associação Brasileira de Saúde Coletiva Av. Dr. Arnaldo, 715 - 2º andar - sl. 3 - Cerqueira César, 01246-904 São Paulo SP Brasil , Tel./FAX: +55 11 3061-8055 - São Paulo - SP - Brazil
E-mail: epidemio_submissao@abrasco.org.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Ir para o topo Reportar erro